journal article·2022-12Open access

Biomimetic PLGA-based nanocomplexes for improved tumor penetration to enhance chemo-photodynamic therapy against metastasis of TNBC

Jialong Fan, Yan Qin, Chang Xiao, Liqin Yuan, Ying Long, Yanzhong Zhao, William Nguyen, Simin Chen, Wei Chen, Xuanming Liu, Bin Liu

Abstract

The combination of chemo-photodynamic therapy has become a promising strategy for cancer by overcoming the limitations of chemotherapy. However, hypoxic microenvironment, poor drug penetration, and metastatic malignant tumors still limited the therapeutic efficacy of this strategy on triple-negative breast cancer (TNBC). Hence, we developed a combinational nanosystem for efficient TNBC therapy by programming tumor microenvironment and improving drug penetration ability. First, a hybrid membrane (HM) camouflaged poly lactic-co-glycolic acid (PLGA) nanosystem was developed for tumor-targeted delivery of capsaicin (Cap) to improve the tumor hypoxic microenvironment via dilating tumor blood vessels with oxygenation and promote the accumulation of nano-drugs in the tumor ([email protected] NPs). After administration of [email protected] NPs, the sequential administration of PLGA co-loaded with Gamabufotalin (CS-6) and photosensitizer Chlorin e6 (Ce6) significantly penetrate into tumor core regions ([email protected]&CS-6 NPs). Our results demonstrated that the sequential administration strategy not only effectively inhibits tumor growth, but also significantly inhibits the metastasis of primary TNBC by reducing the expression of hypoxia-inducible factor 1-alpha (HIF-1α), cyclooxygenase-2 (COX-2), and matrix metalloproteinase-9 (MMP-9) in tumor tissues. The study proved a high efficiency of the sequential treatment strategy by combining the vasodilator of capsaicin and tumor-infiltrating biomimetic nano-drugs for TNBC therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns10.1007/s10549-020-05727-x ↗
2. Metastatic and triple-negative breast cancer: challenges and treatment options10.1007/s13346-018-0551-3 ↗
3. Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy10.1186/s12967-018-1679-0 ↗
4. Primary tumor location predicts the site of local relapse after nipple–areola complex (NAC) sparing mastectomy10.1007/s10549-017-4312-7 ↗
5. The prognostic analysis of clinical breast cancer subtypes among patients with liver metastases from breast cancer10.1007/s10147-011-0336-x ↗
6. High interstitial fluid pressure—an obstacle in cancer therapy10.1038/nrc1456 ↗
7. Rational design of nanoparticles with deep tumor penetration for effective treatment of tumor metastasis
8. Strategies to improve tumor penetration of nanomedicines through nanoparticle design10.1002/wnan.1519 ↗
9. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
10. Self-propelled gemini-like LMWH-scaffold nanodrugs for overall tumor microenvironment manipulation via macrophage reprogramming and vessel normalization10.1021/acs.nanolett.9b04024 ↗
11. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension10.1016/j.cmet.2010.05.015 ↗
12. Nanoparticles of chlorin dimer with enhanced absorbance for photoacoustic imaging and phototherapy10.1002/adfm.201706507 ↗
13. Nanotechnology for multimodal synergistic cancer therapy10.1021/acs.chemrev.7b00258 ↗
14. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy10.1039/C6CS00271D ↗
15. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation10.1073/pnas.1113483108 ↗
16. Prevention of distant lung metastasis after photodynamic therapy application in a breast cancer tumor model10.1166/jbn.2016.2208 ↗
17. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment, Lasers in Surgery and Medicine10.1002/lsm.20339 ↗
18. Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells10.1186/1476-4598-13-203 ↗
19. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition10.1016/j.actbio.2020.06.025 ↗
20. Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer10.18632/oncotarget.10388 ↗
21. Erythrocyte-cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma10.1021/acsnano.7b08355 ↗
22. Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance10.1002/smll.201502388 ↗
23. RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer10.1016/j.biomaterials.2019.119301 ↗
24. Hybrid-cell membrane-coated nanocomplex-loaded chikusetsusaponin IVa methyl ester for a combinational therapy against breast cancer assisted by Ce610.1039/D0BM02211J ↗
25. A novel theranostic nanoplatform based on Pd@ Pt-PEG-Ce6 for enhanced photodynamic therapy by modulating tumor hypoxia microenvironment10.1002/adfm.201706310 ↗
26. Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor10.1038/s41467-019-14199-7 ↗
27. Deep tumor penetrating bioparticulates inspired burst intracellular drug release for precision chemo-phototherapy
28. Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy10.1038/s41565-019-0485-z ↗
29. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size10.1038/nnano.2011.166 ↗
30. Asymmetric silica nanoparticles with tunable head-tail structures enhance hemocompatibility and maturation of immune cells10.1021/jacs.6b12622 ↗
31. Cell membrane-covered nanoparticles as biomaterials10.1093/nsr/nwz037 ↗
32. Metal-based nanostructures/PLGA nanocomposites: antimicrobial activity, cytotoxicity, and their biomedical applications10.1021/acsami.9b19435 ↗
33. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics10.1038/s41565-021-00858-8 ↗
34. Penetration and uptake of nanoparticles in 3D tumor spheroids10.1021/acs.bioconjchem.9b00136 ↗
35. Size-transformable hyaluronan stacked self-assembling peptide nanoparticles for improved transcellular tumor penetration and photo-chemo combination therapy10.1021/acsnano.9b08434 ↗
36. Breast cancer as a systemic disease: a view of metastasis10.1111/joim.12084 ↗
37. Overcoming the Achilles' heel of photodynamic therapy10.1039/C6CS00616G ↗
38. Perfluorocarbon@Porphyrin nanoparticles for tumor hypoxia relief to enhance photodynamic therapy against liver metastasis of colon cancer10.1021/acsnano.0c05617 ↗
39. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma10.1007/s10549-010-1240-1 ↗
40. Vasodilator hydralazine promotes nanoparticle penetration in advanced desmoplastic tumors
41. Tumor oxygenation and hypoxia inducible factor-1 functional inhibition via a reactive oxygen species responsive nanoplatform for enhancing radiation therapy and abscopal effects10.1021/acsnano.8b03590 ↗
42. A pH-sensitive nanomedicine incorporating catalase gene and photosensitizer augments photodynamic therapy and activates antitumor immunity10.1016/j.nantod.2022.101390 ↗
43. Safety of nanoparticles in medicine10.2174/1389450115666140804124808 ↗